3D Bioprinting 2014-2024: Applications, Markets and Players

3D bioprinting constitutes a raft of technologies, commercial and not-yet commercial, which have the potential to significantly impact a number of major markets, including in vitro testing for more efficient drug discovery and toxicity testing of personal consumer products, as well as the clinical fields relating to implant/grafting of human tissue. Though not yet employed within its addressable markets (current bioprinter sales and products are to research and development organisations only), the potential for rapid deployment in some areas already exists, subject to adequate funding being made available. Details of the new report, table of contents and ordering information can be found on Electronics.ca Publications" web site. View the report: 3D Bioprinting 2014-2024: Applications, Markets and Players.